Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative [Globe and Mail, The (Toronto, Canada)]
Takeda Spotlights High-Value, Late-Stage Pipeline Accelerating the Development of Potential Transformative Treatments for Patients in Multiple Therapeutic Areas
Dietary Supplements Market in Japan is Expected to Reach USD 2,310.30 Million by 2033, Growing at a 6.2% CAGR | Future Market Insights, Inc. [Yahoo! Finance]
Takeda Pharmaceutical (TSE:4502) Advances with New Product Update and Strategic Alliances for Growth [Yahoo! Finance]
Takeda Strengthens Oncology Pipeline with Elritercept through Licensing Agreement with Keros Therapeutics